Xenetic Biosciences- Warrants (19/07/2024) PEG Ratio

The latest PEG ratio for XBIOW is -5.74. That is below the Healthcare sector average of 4.09. Investors often review this figure alongside Xenetic Biosciences- Warrants (19/07/2024)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, XBIOW currently prints -5.74 for PEG ratio, while the sector average sits near 4.09. That is roughly 240.2% below the sector mean. Large gaps often invite a closer look at Xenetic Biosciences- Warrants (19/07/2024)'s growth, margins, and balance sheet.

A PEG ratio of -5.74 for Xenetic Biosciences- Warrants (19/07/2024) is not 'good' or 'bad' on its own. Compare it with the peer average (4.09) and with XBIOW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting XBIOW's PEG ratio (-5.74), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Xenetic Biosciences- Warrants (19/07/2024)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.